MIVI Neuroscience Announces First Patient Enrolled in EVAQ Clinical Study for Ischemic Stroke Treatment ...Middle East

EDEN PRAIRIE, Minn., Dec. 1, 2020 /PRNewswire/ -- MIVI Neuroscience, Inc. announced that it has enrolled the first patient in the Food and Drug Administration approved Investigational Device Exemption EVAQ Clinical Study. The procedure took place at Hôpital de Purpan in Toulouse, France....

Read More Details
Finally We wish PressBee provided you with enough information of ( MIVI Neuroscience Announces First Patient Enrolled in EVAQ Clinical Study for Ischemic Stroke Treatment )

Also on site :

• Country 'MVP' Refunds Entire Audience Mid-Concert and Fans 'Cannot Believe He Did That'
• With Property Seized and Federal Funding Uncertain, Montana Asbestos Clinic Fights for Its Life
• Flamengo vs Chelsea Preview, prediction, lineups, betting tips & odds .. FIFA Club World Cup 2025